期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分析ER、PR表达在乳腺癌中辅助内分泌治疗的作用

暂未订购
导出
摘要 乳腺癌细胞中的ER、PR表达用于指导辅助内分泌治疗和评价患者预后的参考指标。三苯氧胺在临床上的广泛应用有效降低了乳腺癌患者的复发率。第3代芳香化酶抑制剂的出现使辅助内分泌治疗的疗效得到了进一步提高。
作者 李今 雷莹
机构地区 陕西省妇幼保健院乳腺外科
出处 《中国社区医师（医学专业）》 2009年第21期130-130,共1页
关键词 乳腺癌 ER/PR 辅助内分泌治疗
分类号 R737.9 [医药卫生—肿瘤] R749.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献2

二级参考文献15

  • 1Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer[J]. J Natl Cancer Inst, 1998,90(21 ) :1601-1608.
  • 2Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer, seventh international conference on adjuvant therapy of primary breast cancer[J]. J Clin Oncol,2001,19(18) :3817-27.
  • 3National Institutes of Health Consensus Development Conference[M]. J Nail Cancer Inst Monogr,2001,30 : 151-152.
  • 4Carlson RW, Edge SB, Theriault RL. NCCN: Breast cancer[J] ,Cancer Control,2001,8(6) :54-61.
  • 5Elary Breast Cancer Treatment Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials[ J ]. Lancet, 1998,352 ( 2 ) : 930-042.
  • 6Nabholtz JM, Pienkowski T, Mackey J, et al. Phase Ⅲ trial comparing TAC with FAC in the adjuvant ueatment of node positive breast cancer patients: interim analysis[A]. ASCO 2002.
  • 7Citron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concureeent combination chemotherapy as posterative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and Leukemia Group B trial 9741[J]. J Clin Oncol,2003,21 (7) : 1431-1439.
  • 8Fisher B, Anderson S, Wolmark N, et al. Chemotherapy with or without utmoxifen for patients with ER-negative breast cancer and negative nodes: Result from NSABP B23[ J ]. J Clin Oncol,2001,19(4) :931-942.
  • 9Hutchins L, Green S, Ravdin P, eta 1. CMF versus CAF with and without tamoxifen in highrisk node negative breast cancer patients and a natund histroy follow-up study in low-risk node negative patients:First results of Intergroup trial INT 0102[J].Proc Am Soc Clin Oncol,1998,17:la.
  • 10Levine M, Bramwell V, Pritchard K, et al. Randomized trial of intensive cyclophosphamide,epirubicin, and fluorouracil chemotherapy compared with cyclophoephamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group[J]. J Clin Oncol, 1998,16(8) :2651-2658.

共引文献9

中国社区医师（医学专业）
2009年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部